The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV
Abstract
We studied the frequency, severity, and clinical correlations of cerebral amyloid angiopathy (CAA) in 117 CERAD subjects with autopsy-confirmed AD. Eighty-three percent showed at least a mild degree of amyloid angiopathy. Thirty of 117 brains (25.6%) showed moderate to severe CAA affecting the cerebral vessels in one or more cortical regions. These brains also showed a significantly higher frequency of hemorrhages or ischemic lesions than those of subjects with little or no amyloid angiopathy (43.3% versus 23.0%; odds ratio = 2.6, 95% CI = 1.1 to 6.2) High CAA scores also correlated with the presence of cerebral arteriosclerosis and with older age at onset of dementia. Our findings suggest that factors contributing to non-AD-related vascular pathology (e.g., atherosclerosis) may play a role in amyloid deposition in cerebral vessels in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is strong experimental evidence that the APOE isoforms are major determinants of the amount and quality of amyloid-β peptide (Aβ) and amyloid burden in the brain that develops during aging.15–17”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [16]
In the citing paper
“Atherosclerosis has been associated with AD and cerebral angiopathy in humans [43], [44], and recent findings indicate that vascular risk factors and neurovascular dysfunction play integral roles in the pathogenesis of AD [45].”
From ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage (2011) · cites this paper as [44]
In the citing paper
“Neuropathological examination of patient brains harboring APP duplications show abundant plaque and tangle pathology as well cerebral amyloid angiopathy (CAA)”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [249]
Citations
Cites
Arteriovenous malformations of the brain: natural history in unoperated patients.
Crawford, P. M., West, C. R., Chadwick, D. W., & Shaw, M. D. M. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.1.1 · Cited by 814
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1988) · Annals of Neurology · doi:10.1002/ana.410240110 · Cited by 362
Self-citationGasset, M., Baldwin, M. A., Fletterick, R. J., & Prusiner, S. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.1 · Cited by 307
Pre‐and Postmortem Influences on Brain RNA
BARTON, A. J. L., Pearson, R. C. A., Najlerahim, A., & Harrison, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03532.x · Cited by 269
Clinicopathologic Studies of Primary Cerebral Amyloid Angiopathy
Okazaki, H., Reagan, T. J., & Campbell, R. J. (1979) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18993-3 · Cited by 259
Olichney, J. M., Hansen, L., Hofstetter, C., Grundman, M., Katzman, R., & Thal, L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310076019 · Cited by 251
Self-citationEvaluation of thermography in the diagnosis of selected entrapment neuropathies
So, Y. T., Olney, R. K., & Aminoff, M. J. (1989) · Neurology · doi:10.1212/wnl.39.1.1 · Cited by 171
Roher, A. E., Palmer, K. C., Yurewicz, E. C., Ball, M. J., & Greenberg, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09834.x · Cited by 144
Immunocytochemical localization of estrogen-induced progestin receptors in guinea pig brain
Blaustein, J. D., King, J. C., Toft, D. O., & Turcotte, J. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90664-6 · Cited by 144
Research works printed but not linked: 15
- Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983;14:924-928.
- Glenner GG, Henry JH, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1981;1:120-129.
- Armstrong RA, Myers D, Smith CU. The ratio of diffuse to mature beta/A4 deposits in Alzheimer's disease varies in cases with and without congophilic angiopathy. Dementia 1993;4:251-255.
- Lopez O, Claassen D, Boller F. Alzheimer's disease, cerebral amyloid angiopathy, and dementia of acute onset. Aging 1991;3:171-175.
- Aronson MK, Ooi WL, Geva DL, et al. Dementia. Age-dependent incidence, prevalence, and mortality in the old old. Arch Intern Med 1991;151:989-992.
- Gilbert JJ, Vinters HV. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983;14:915-923.
- Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986;45:79-90.
- Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finkelstein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993;43:2073-2079.
- Hendriks L, Van DC, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nature Genet 1992;1:218-221.
- Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
- Ishihara T, Takahashi M, Yokota T, et al. The significance of cerebral vascular amyloid in the aetiology of superficial (lobar) cerebral haemorrhage and its incidence in the elderly population. J Pathol 1991;165:229-234.
- Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987;234:371-376.
- Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994;145:452-460.
- Wisniewski HM, Wegiel J. Beta-amyloid formation by myocytes of amyloid vessels. Acta Neuropathol 1994;87:233-241.
- Kawai M, Kalaria RN, Cras P, et al. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer's disease. Brain Res 1993;63:142-146.
Cited by
Sorted by citations
Items 101–200 of 560
Chalmers, K., Wilcock, G. K., & Love, S. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00457.x · Cited by 156
Kook, S.-Y., Lee, K.-M., Kim, Y., Cha, M.-Y., Kang, S., Baik, S., Lee, H., Park, R., & Mook‐Jung, I. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.26 · Cited by 129
Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease
Huang, Z., Wong, L., Su, Y., Huang, X., Wang, N., Chen, H., & Yi, C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100857 · Cited by 135
Li, L., Cao, D., Garber, D. W., Kim, H., & Fukuchi, K.-I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63572-9 · Cited by 105
Cerebral amyloid angiopathy with and without hemorrhage
Charidimou, A., Martínez‐Ramírez, S., Shoamanesh, A., Filho, J. O., Frosch, M. P., Vashkevich, A., Ayres, A. M., Rosand, J. M., Gurol, M. E., Greenberg, S. M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001398 · Cited by 126
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
Alzheimer disease and risk of stroke
Chi, N., Chien, L., Ku, H., Hu, C., & Chiou, H. (2013) · Neurology · doi:10.1212/wnl.0b013e31828250af · Cited by 124
Khan, A., Kalaria, R. N., Corbett, A., & Ballard, C. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 130
Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein
Melchor, J. P., McVoy, L., & Nostrand, W. E. V. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742209.x · Cited by 125
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
Liccardo, D., Marzano, F., Carraturo, F., Guida, M., Femminella, G. D., Bencivenga, L., Agrimi, J., Addonizio, A., Melino, I., Valletta, A., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00683 · Cited by 148
van Veluw, S. J., Charidimou, A., van der Kouwe, A. J. W., Lauer, A., Reijmer, Y. D., Costantino, I. M., Gurol, M. E., Biessels, G. J., Frosch, M. P., Viswanathan, A., et al. (2016) · Brain · doi:10.1093/brain/aww229 · Cited by 124
工藤, 有., Mizuno, T., Yamada, K., Shiga, K., Yoshikawa, K., Mori, S., Nishimura, T., Nakajima, K., & Nakagawa, M. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000092958 · Cited by 120
Attems, J., Quass, M., Jellinger, K. A., & Lintner, F. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.013 · Cited by 126
Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease
Shinohara, M., Murray, M. E., Frank, R. D., Shinohara, M., DeTure, M., Yamazaki, Y., Tachibana, M., Atagi, Y., Davis, M. D., Liu, C.-C., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1580-y · Cited by 123
The vascular contribution to Alzheimer's disease
Altman, R., & Rutledge, J. C. (2010) · Clinical Science · doi:10.1042/cs20100094 · Cited by 93
Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease
Yates, P. A., Sirisriro, R., Villemagne, V. L., Farquharson, S., Masters, C. L., Rowe, C. C., & For the AIBL Research Group (2011) · Neurology · doi:10.1212/wnl.0b013e318221ad36 · Cited by 130
Nikolic, W. V., Hou, H., Town, T., Zhu, Y., Giunta, B. N., Sanberg, C. D., Zeng, J., Luo, D., Ehrhart, J. C., Mori, T., et al. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0018 · Cited by 114
Pathophysiology of Hypoperfusion of the Precuneus in Early A lzheimer's Disease
Miners, J. S., Palmer, J. C., & Love, S. (2015) · Brain Pathology · doi:10.1111/bpa.12331 · Cited by 109
A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease
Crawford, F., Freeman, M. J., Schinka, J. A., Abdullah, L. I., Gold, M., Hartman, R. D., Krivian, K., Morris, M. D., Richards, D., Duara, R., et al. (2000) · Neurology · doi:10.1212/wnl.55.6.763 · Cited by 109
Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease
Heyman, A., Fillenbaum, G. G., Gearing, M., Mirra, S. S., Welsh-Bohmer, K. A., Peterson, B. L., & Pieper, C. F. (1999) · Neurology · doi:10.1212/wnl.52.9.1839 · Cited by 109
Self-citationPathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia
Barker, R. M., Ashby, E. L., Wellington, D., Barrow, V. M., Palmer, J. C., Kehoe, P. G., Esiri, M. M., & Love, S. (2014) · Brain · doi:10.1093/brain/awu040 · Cited by 110
Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease
Davies, D. A., Adlimoghaddam, A., & Albensi, B. C. (2021) · Cells · doi:10.3390/cells10081884 · Cited by 112
Macrophages in Alzheimer’s disease: the blood-borne identity
Gate, D., Rezai-Zadeh, K., Jodry, D., Rentsendorj, A., & Town, T. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0422-7 · Cited by 107
Kövari, E., Herrmann, F. R., Hof, P. R., & Bouras, C. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12003 · Cited by 105
Clinical phenotypes of Cerebral Amyloid Angiopathy
Maia, L. F., Mackenzie, I. R., & Feldman, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.054 · Cited by 106
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Head, E., Phelan, M. J., Doran, E., Kim, R. C., Poon, W. W., Schmitt, F. A., & Lott, I. T. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0499-4 · Cited by 105
Cerebral microbleeds and cognition in cerebrovascular disease: An update
Charidimou, A., & Werring, D. J. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.052 · Cited by 106
Aliev, G., Palacios, H. H., Walrafen, B., Lipsitt, A. E., Obrenovich, M. E., & Morales, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.015 · Cited by 102
Alzheimer's disease pathophysiology in the Retina
Gaire, B. P., Koronyo, Y., Fuchs, D.-T. S., Shi, H., Rentsendorj, A., Danziger, R., Vit, J., Mirzaei, N., Doustar, J., Sheyn, J., et al. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101273 · Cited by 107
Vitali, P., Migliaccio, R., Agosta, F., Rosen, H., & Geschwind, M. D. (2008) · Seminars in Neurology · doi:10.1055/s-0028-1083695 · Cited by 105
Mori, T., Koyama, N., Tan, J., Segawa, T., Maeda, M., & Town, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004280 · Cited by 103
Links Between the Pathology of Alzheimer's Disease and Vascular Dementia
Sadowski, M., Pankiewicz, J. E., Scholtzova, H., Li, Y., Quartermain, D., Duff, K., & Wısnıewskı, T. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023612.66691.e6 · Cited by 100
Polymorphisms in the PON gene cluster are associated with Alzheimer disease
Erlich, P. M., Lunetta, K. L., Cupples, L. A., Huyck, M., Green, R. C., Baldwin, C. T., & Farrer, L. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi428 · Cited by 101
Animal models of cerebral β-amyloid angiopathy
Walker, L. C. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00017-9 · Cited by 100
Disruption of blood-brain barrier in Alzheimer disease pathogenesis
Kook, S. Y., Hong, H., Moon, M., & Mook‐Jung, I. (2013) · Tissue Barriers · doi:10.4161/tisb.23993 · Cited by 101
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias
Turner, R. S., Stubbs, T., Davies, D. A., & Albensi, B. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00496 · Cited by 98
Staffaroni, A., Elahi, F., McDermott, D., Marton, K., Karageorgiou, E., Sacco, S., Paoletti, M., Caverzasi, E., Hess, C., Rosen, H., et al. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608808 · Cited by 91
The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier
Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93
Retinal Vasculopathy in Alzheimer’s Disease
Shi, H., Koronyo, Y., Rentsendorj, A., Fuchs, D.-T. S., Sheyn, J., Black, K. L., Mirzaei, N., & Koronyo‐Hamaoui, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.731614 · Cited by 91
Cerebrovascular disease and dementia
Knopman, D. S. (2007) · British Journal of Radiology · doi:10.1259/bjr/75681080 · Cited by 92
Tayler, H. M., Miners, J. S., Güzel, Ö., MacLachlan, R. A., & Love, S. (2021) · Brain Pathology · doi:10.1111/bpa.12935 · Cited by 90
Dietary fats, cerebrovasculature integrity and Alzheimer’s disease risk
Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., Lam, V., & Mamo, J. C. L. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.10.004 · Cited by 89
Matrix metalloproteinases in Alzheimer’s disease and concurrent cerebral microbleeds.
Duits, F. H., Hernandez-Guillamon, M., Montaner, J., Goos, J. D. C., Montañola, A., Wattjes, M. P., Barkhof, F., Scheltens, P., Teunissen, C. E., & van der Flier, W. M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143186 · Cited by 92
Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., JENNINGS, K. H., & Howlett, D. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7717 · Cited by 89
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
Smith, E. E., & Greenberg, S. M. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0048-4 · Cited by 88
Risk Factors for Cerebral Amyloid Angiopathy in the Elderly
Yamada, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04797.x · Cited by 88
Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia
Abrahamson, E. E., & Ikonomović, M. D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113257 · Cited by 91
Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy
Attems, J., Lauda, F., & Jellinger, K. A. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0674-4 · Cited by 87
Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Pasquier, F., & Maurage, C. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.09.031 · Cited by 89
Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings
Charidimou, A., Krishnan, A. S., Werring, D. J., & Jäger, H. R. (2013) · Neuroradiology · doi:10.1007/s00234-013-1175-4 · Cited by 87
The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 87
Roles of vascular risk factors in the pathogenesis of dementia
Takeda, S., Rakugi, H., & Morishita, R. (2019) · Hypertension Research · doi:10.1038/s41440-019-0357-9 · Cited by 94
De Reuck, J., Maurage, C.-A., Deramecourt, V., Pasquier, F., Cordonnier, C., Leys, D., & Bordet, R. (2018) · Folia Neuropathologica · doi:10.5114/fn.2018.76610 · Cited by 84
Comorbidity in Dementia: Update of an Ongoing Autopsy Study
Magaki, S., Yong, W. H., Khanlou, N., Tung, S., & Vinters, H. V. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12977 · Cited by 84
Sani, S., Traul, D., Klink, A., Niaraki, N., Gonzalo-Ruiz, A., Wu, C.-K., & Geula, C. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0626-5 · Cited by 83
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87
Cerebral Hypoperfusion and the Energy Deficit in A lzheimer's Disease
Love, S., & Miners, J. S. (2016) · Brain Pathology · doi:10.1111/bpa.12401 · Cited by 86
Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice
Zhang, X., Hu, J., Zhong, L., Wang, N., Yang, L., Liu, C., Li, H., Wang, X., Zhou, Y., Zhang, Y., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.032 · Cited by 86
Cerebral amyloid angiopathy as a cause of neurodegeneration
Smith, E. E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14157 · Cited by 86
Ringman, J. M., Sachs, M. C., Zhou, Y. F., Monsell, S. E., Saver, J. L., & Vinters, H. V. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.681 · Cited by 85
Assessing White Matter Ischemic Damage in Dementia Patients by Measurement of Myelin Proteins
Barker, R. M., Wellington, D., Esiri, M. M., & Love, S. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.46 · Cited by 79
Graff‐Radford, J., Botha, H., Rabinstein, A. A., Gunter, J. L., Przybelski, S. A., Lesnick, T. G., Huston, J., Flemming, K. D., Preboske, G. M., Senjem, M. L., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006780 · Cited by 80
Mori, T., Koyama, N., Yokoo, T., Segawa, T., Maeda, M., Sawmiller, D. R., Tan, J., & Town, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012330 · Cited by 82
Cardiovascular factors in Alzheimer's disease
Stewart, R. J. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.2.143 · Cited by 78
Rabin, J. S., Nichols, E., Joie, R. L., Casaletto, K. B., Palta, P., Dams-O’Connor, K., Kumar, R. G., George, K. M., Satizábal, C. L., Schneider, J. A., et al. (2022) · Brain · doi:10.1093/brain/awac178 · Cited by 80
De Reuck, J., Auger, F., Cordonnier, C., Deramecourt, V., Durieux, N., Pasquier, F., Bordet, R., Maurage, C. A., & Leys, D. (2011) · Cerebrovascular Diseases · doi:10.1159/000324391 · Cited by 76
Proinflammatory and Vasoactive Effects of Aβ in the Cerebrovasculature
Townsend, K. P., Obregon, D. F., QUADROS, A., Patel, N. S., Volmar, C., Paris, D., & MULLAN, M. J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04799.x · Cited by 77
Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage
Pezzini, A., Zotto, E. D., Volonghi, I., Giossi, A., Costa, P., & Padovani, A. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788682047 · Cited by 77
Shared genetic contribution to ischemic stroke and Alzheimer's disease
Traylor, M., Adib‐Samii, P., Harold, D., the Alzheimer's Disease Neuroimaging Initiative, T. I. S. G. C. (., Dichgans, M., Williams, J., Lewis, C. M., Markus, H. S., & and the METASTROKE and International Genomics of Alzheimer's Project (IGAP) investigators (2016) · Annals of Neurology · doi:10.1002/ana.24621 · Cited by 71
Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease
Benedictus, M. R., Goos, J. D. C., Binnewijzend, M. A. A., Muller, M., Barkhof, F., Scheltens, P., Prins, N. D., & van der Flier, W. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.023 · Cited by 81
Divecha, Y. A., Rampes, S., Tromp, S., Boyanova, S., Fleckney, A. L., Fidanboylu, M., & Thomas, S. A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100052 · Cited by 83
Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy
Love, S. (2009) · Frontiers in bioscience · doi:10.2741/3567 · Cited by 78
Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., Wellington, C. L., Johnsen, R. D., Dhaliwal, S. S., & Mamo, J. C. L. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509992194 · Cited by 76
Paris, D., Quadros, A., Humphrey, J., Patel, N. S., Crescentini, R. M., Crawford, F., & MULLAN, M. J. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.061 · Cited by 75
Yang, Z., Slavin, M. J., & Sachdev, P. S. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.105 · Cited by 74
The cerebromicrovasculature: A key player in the pathogenesis of Alzheimer's disease
Grammas, P., Yamada, M., & Zloković, B. V. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4311 · Cited by 74
Engineering Theranostic Nanovehicles Capable of Targeting Cerebrovascular Amyloid Deposits
Agyare, E. K., Jaruszewski, K. M., Curran, G. L., Rosenberg, J. T., Grant, S. C., Lowe, V. J., Ramakrishnan, S., Paravastu, A. K., Poduslo, J. F., & Kandimalla, K. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.010 · Cited by 71
Ryan, N. S., Biessels, G. J., Kim, L. G., Nicholas, J. M., Barber, P. A., Walsh, P., Gami‐Patel, P., Morris, H. R., de Bastos-Leite, A. J., Schott, J. M., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.026 · Cited by 72
Koronyo‐Hamaoui, M., Sheyn, J., Hayden, E. Y., Li, S., Fuchs, D.-T. S., Regis, G. C., Lopes, D. H. J., Black, K. L., Bernstein, K. E., Teplow, D. B., et al. (2019) · Brain · doi:10.1093/brain/awz364 · Cited by 75
Paris, D., Town, T., Parker, T. A., Tan, J., Humphrey, J., Crawford, F., & MULLAN, M. J. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7055 · Cited by 71
Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease
Mastaglia, F. L., Johnsen, R. D., Byrnes, M. L., & Kakulas, B. A. (2002) · Movement Disorders · doi:10.1002/mds.10295 · Cited by 70
Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01076-4 · Cited by 71
VEGFR1 and VEGFR2 in Alzheimer’s Disease
Harris, R., Miners, J. S., Allen, S. J., & Love, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170745 · Cited by 70
Neuropathology of Alzheimer's Disease
Mott, R. T., & Hulette, C. M. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.003 · Cited by 71
Su, G. C., Arendash, G. W., Kalaria, R. N., Bjugstad, K. B., & MULLAN, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01143-3 · Cited by 70
Cerebral small vessel diseases: cerebral microangiopathies
Ringelstein, E. B., & Nabavi, D. G. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000162861.26971.03 · Cited by 69
The role of inflammatory processes in Alzheimer’s disease
Broussard, G. J., Mytar, J. O., Li, R., & Klapstein, G. J. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0130-z · Cited by 71
Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases
Pandian, S. R. K., Vijayakumar, K. K., Murugesan, S., & Kunjiappan, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09575 · Cited by 77
Richard, E., Kuiper, R., Dijkgraaf, M. G. W., van Gool, W. A., & for the Evaluation of Vascular care in Alzheimer's disease Study Group (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02217.x · Cited by 67
Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage
Lee, J., Yin, K., Hsin, I., Chen, S., Fryer, J. D., Holtzman, D. M., Hsu, C. Y., & Xu, J. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.041 · Cited by 70
Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.
Perry, G., Smith, M. A., McCann, C., Siedlak, S., Jones, P. K., & Friedland, R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00006-7 · Cited by 69
Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy
Richard, E., Carrano, A., Hoozemans, J. J., van Horssen, J., van Haastert, E. S., Eurelings, L. S., de Vries, H. E., Thal, D. R., Eikelenboom, P., van Gool, W. A., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181fab558 · Cited by 71
Moon, W., Lim, C., Ha, I. H., Kim, Y., Moon, Y., Kim, H.-J., & Han, S. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20952012 · Cited by 67
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
Canepa, E., & Fossati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573324 · Cited by 67
CD40 signaling and Alzheimer's disease pathogenesis
Town, T., Tan, J., & MULLAN, M. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00044-4 · Cited by 61
Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway
Paris, D., Town, T., Mori, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00111-6 · Cited by 66
Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Maurage, C., & Pasquier, F. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03329.x · Cited by 64
Choroidal thinning: Alzheimer's disease and aging
Cunha, J. P., Proença, R. P., Dias‐Santos, A., Melância, D., de Almeida, R. M., Águas, H., Santos, B. O., Alves, M., Ferreira, J., Papoila, A. L., et al. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.03.004 · Cited by 63
Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits
Sun, H.-L., Chen, S.-H., Yu, Z.-Y., Cheng, Y., Tian, D.-Y., Fan, D.-Y., He, C.-Y., Wang, J., Sun, P.-Y., Chen, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0842-1 · Cited by 56
Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease
Adlimoghaddam, A., Snow, W. M., Stortz, G., Perez, C., Djordjevic, J., Goertzen, A. L., Ko, J. H., & Albensi, B. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.008 · Cited by 61
Metadata
- Authors
- Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A.
- Affiliations
- University of California San Diego (US)
- Emory University (US)
- Washington University in St. Louis (US)
- University of Washington (US)
- Duke University (US)
- Venue
- Neurology
- Published
- 1996-06
- Volume
- 46
- Issue
- 6
- Pages
- 1592-1596
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2020068741
- Cited by
- 561
- References
- 26
- Citations by year
- 2026: 5 · 2025: 26 · 2024: 18 · 2023: 10 · 2022: 20 · 2021: 38 · 2020: 32 · 2019: 23 · 2018: 17 · 2017: 26 · 2016: 27 · 2015: 30 · 2014: 20 · 2013: 23 · 2012: 17
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chinese Academy of Agricultural Sciences
- National Institute on Aging (AG06790, AG05131, P50AG005131, U01AG006790)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- cerebral amyloid angiopathy, Alzheimer's disease, intracerebral hemorrhage, ischemic lesions, cerebral arteriosclerosis, atherosclerosis, vascular pathology
- MeSH terms
- Aged, Alzheimer Disease, Arteriosclerosis, Brain, Cerebral Hemorrhage, Brain Ischemia, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, United States, Comorbidity, Cerebral Amyloid Angiopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review